Misako Ichikawa

401 total citations
8 papers, 369 citations indexed

About

Misako Ichikawa is a scholar working on Oncology, Molecular Biology and Pharmacology. According to data from OpenAlex, Misako Ichikawa has authored 8 papers receiving a total of 369 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Oncology, 4 papers in Molecular Biology and 2 papers in Pharmacology. Recurrent topics in Misako Ichikawa's work include Drug Transport and Resistance Mechanisms (7 papers), Cancer therapeutics and mechanisms (2 papers) and Glycosylation and Glycoproteins Research (2 papers). Misako Ichikawa is often cited by papers focused on Drug Transport and Resistance Mechanisms (7 papers), Cancer therapeutics and mechanisms (2 papers) and Glycosylation and Glycoproteins Research (2 papers). Misako Ichikawa collaborates with scholars based in Japan. Misako Ichikawa's co-authors include Tomoyuki Sumizawa, Yasuo Kuwazuru, Akihiko Yoshimura, S Akiyama, Shin-ichi Akiyama, Akihiko Yoshimura, Shun‐ichi Ikeda, Taizo Uda, Tatsuhiko Furukawa and Kimiharu Uozumi and has published in prestigious journals such as Journal of Biological Chemistry, Biochemical and Biophysical Research Communications and Cancer Letters.

In The Last Decade

Misako Ichikawa

8 papers receiving 360 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Misako Ichikawa Japan 7 293 154 74 53 46 8 369
Tanya Bagrij United Kingdom 8 349 1.2× 141 0.9× 145 2.0× 64 1.2× 46 1.0× 11 433
J. Van Kapel Netherlands 10 158 0.5× 193 1.3× 62 0.8× 21 0.4× 40 0.9× 16 335
Lisa M. Breuninger United States 3 163 0.6× 80 0.5× 49 0.7× 33 0.6× 27 0.6× 4 254
Hideyuki Tanimura Japan 12 347 1.2× 297 1.9× 54 0.7× 100 1.9× 34 0.7× 16 574
Kazuhiro Kagotani Japan 10 407 1.4× 278 1.8× 184 2.5× 122 2.3× 38 0.8× 16 646
Monika Vasa Canada 10 243 0.8× 174 1.1× 95 1.3× 135 2.5× 32 0.7× 12 444
Kae Yanase Japan 6 190 0.6× 174 1.1× 49 0.7× 28 0.5× 38 0.8× 8 337
Erin O’Brien Canada 4 218 0.7× 321 2.1× 34 0.5× 48 0.9× 17 0.4× 6 441
V. Nüßler Germany 10 119 0.4× 146 0.9× 27 0.4× 17 0.3× 14 0.3× 23 336
H He China 4 224 0.8× 173 1.1× 69 0.9× 21 0.4× 57 1.2× 6 384

Countries citing papers authored by Misako Ichikawa

Since Specialization
Citations

This map shows the geographic impact of Misako Ichikawa's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Misako Ichikawa with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Misako Ichikawa more than expected).

Fields of papers citing papers by Misako Ichikawa

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Misako Ichikawa. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Misako Ichikawa. The network helps show where Misako Ichikawa may publish in the future.

Co-authorship network of co-authors of Misako Ichikawa

This figure shows the co-authorship network connecting the top 25 collaborators of Misako Ichikawa. A scholar is included among the top collaborators of Misako Ichikawa based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Misako Ichikawa. Misako Ichikawa is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

8 of 8 papers shown
1.
Ichikawa, Misako, et al.. (1991). Glycosylation of P-glycoprotein in a multidrug-resistant KB cell line, and in the human tissues. Biochimica et Biophysica Acta (BBA) - General Subjects. 1073(2). 309–315. 32 indexed citations
2.
Ichikawa, Misako, et al.. (1991). Interaction of organic chemicals with P-glycoprotein in the adrenal gland, kidney, and a multidrug-resistant KB cell.. Journal of Biological Chemistry. 266(2). 903–908. 34 indexed citations
3.
Kuwazuru, Yasuo, Akihiko Yoshimura, Shuichi Hanada, et al.. (1990). Expression of the multidrug transporter, P‐glycoprotein, in chronic myelogenous leukaemia cells in blast crisis. British Journal of Haematology. 74(1). 24–29. 82 indexed citations
4.
Yoshimura, Akihiko, et al.. (1990). Novel screening method for agents that overcome classical multidrug resistance in a human cell line. Cancer Letters. 50(1). 45–51. 29 indexed citations
5.
Ichikawa, Misako, Akihiko Yoshimura, Tatsuhiko Furukawa, Tomoyuki Sumizawa, & Shin-ichi Akiyama. (1990). Modulators of the multidrug-transporter, P-glycoprotein, exist in the human plasma. Biochemical and Biophysical Research Communications. 166(1). 74–80. 25 indexed citations
6.
Yoshimura, Akihiko, Yasuo Kuwazuru, Tomoyuki Sumizawa, et al.. (1989). Biosynthesis, processing and half-life of P-glycoprotein in a human multidrug-resistant KB cell. Biochimica et Biophysica Acta (BBA) - General Subjects. 992(3). 307–314. 40 indexed citations
7.
Yoshimura, Akihiko, Yasuo Kuwazuru, Tomoyuki Sumizawa, et al.. (1989). Cytoplasmic Orientation and Two-domain Structure of the Multidrug Transporter, P-glycoprotein, Demonstrated with Sequence-specific Antibodies. Journal of Biological Chemistry. 264(27). 16282–16291. 124 indexed citations
8.
SEKIZAWA, Yasuharu, et al.. (1986). Nitroblue Tetrazolium Reduction of Rice Leaf Slices Stimulated with Blast Fungus Hyphal Component. Agricultural and Biological Chemistry. 50(6). 1427–1436. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026